Skip to main content

Alexion Pharmaceuticals, Inc.

ALXNDelisted Jul 21, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0000899866

Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 712 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
712
Q2 2021, −35 vs. previous quarter
13F value
$39.1B
Reported value at the end of Q2 2021
Superinvestors holding
2
At the end of Q2 2021

From SEC filings, in USD.

Revenue, FY2020
$6.07B
+21.6% year over year
Net income, FY2020
$603.4M
−74.9% year over year
Free cash flow, FY2020
$2.90B
+50.0% year over year
Revenue, Q1 FY2021
$1.64B
+13.3% year over year

Revenue flow, FY2020

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Superinvestors holding ALXN, Q2 2021

Go to the superinvestors tab

2 superinvestors report holding Alexion Pharmaceuticals, Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Soros Fund Management

George Soros

1.7%

Alexion Pharmaceuticals, Inc.'s share of the portfolio

Shares
500,001
Value
$91.9M

Maverick Capital

Lee Ainslie

<0.1%

Alexion Pharmaceuticals, Inc.'s share of the portfolio

Shares
11,420
Value
$2.10M

Latest insider trades

See all insider trades

Open-market purchases and sales by Alexion Pharmaceuticals, Inc. insiders from Form 4, newest first.

No open-market purchases or sales by Alexion Pharmaceuticals, Inc. insiders are on file.

Top 10 13F holders, Q2 2021

See all 712 holders

The largest institutional positions in Alexion Pharmaceuticals, Inc. at the end of Q2 2021; share changes are against Q1 2021.

Institutions holding ALXN in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc20,367,300$3.74B0.09%+798,317+4.1%Added
BlackRock Inc.17,495,607$3.21B0.09%−54,688−0.3%Reduced
State Street Corp10,033,808$1.84B0.10%+156,274+1.6%Added
Farallon Capital Management, L.L.C.7,707,500$1.42B6.83%+1,932,500+33.5%Added
HBK Investments L P6,600,000$1.21B11.63%+875,000+15.3%Added
Davidson Kempner Capital Management LP5,473,378$1.01B7.84%+1,409,202+34.7%Added
Adage Capital Partners GP, L.L.C.5,238,014$962.3M1.88%+995,635+23.5%Added
Pentwater Capital Management LP4,933,200$906.3M9.31%+643,956+15.0%Added
Millennium Management LLC4,829,380$887.2M1.14%+2,276,841+89.2%Added
UBS Oconnor LLC4,428,122$813.5M7.28%+2,861,349+182.6%Added

3 members of Congress reported 12 trades in Alexion Pharmaceuticals, Inc. since 2020. Newest filings:

  1. James R. Langevin

    House · RI · Aug 14, 2021

    Sell$15K-$50K

  2. Dean Phillips

    House · MN · Aug 13, 2021

    Sell$1K-$15K

  3. Dean Phillips

    House · MN · Feb 13, 2021

    Buy$1K-$15K

  4. Gilbert Ray Cisneros, Jr.

    House · CA · Jan 11, 2021

    Sell (partial)$50K-$100K

  5. Gilbert Ray Cisneros, Jr.

    House · CA · Jan 11, 2021

    Sell (partial)$15K-$50K